This study is not yet accepting patients

Student Pharmacist Non-Pharmacological Intervention on Type 2 Diabetes Management in Older Asian Adult Populations

a study on Diabetes Diabetes Type 2

Summary

Eligibility
for people ages 50 years and up (full criteria)
Dates
study started
completion around
Principal Investigator
by Crystal Zhou, PharmD
Headshot of Crystal Zhou
Crystal Zhou

Description

Summary

This study is being done to assess the impact of student pharmacist involvement on blood glucose control through non-pharmacological interventions in people of Asian and Asian descent over the age of 50 with type 2 diabetes. This study team is trying to advance the field of pharmacy and expand the roles of student pharmacists.

Official Title

Student Pharmacist Intervention on Type 2 Diabetes Management in Older Adult Populations

Details

This study aims to assess the clinical impact of student pharmacist-led interventions on glycemic control in adult populations. This study will specifically target adults aged 50 years and older of Asian or Asian-descent with diagnosed type 2 diabetes, residing in San Francisco. The goal of the study is to demonstrate the utility of pharmacy students in a community setting on chronic disease management through patient-specific education and interventions. The aims of this study are to compare glycemic control in patients with type 2 diabetes who receive continuous assessment and non-pharmacological counseling from student pharmacists versus those who do not. Specifically, this study will evaluate:

  1. The impact of student pharmacist assessments and personalized recommendations on diet, exercise, and adherence to treatment regimens, and their lasting effects on blood glucose control.
  2. If participants perceived any value and effect of student pharmacist involvement in managing chronic diseases.

Keywords

Type 2 Diabetes Mellitus (T2DM), student pharmacist, non-pharmacological, diabetes, management, SPY-DM, glucose control, Asian, Older adult, Diabetes Mellitus, Type 2 Diabetes Mellitus

Eligibility

You can join if…

Open to people ages 50 years and up

  • Adults ≥ 50 years old
  • Asian or Asian-descent
  • Diagnosed with T2DM
  • A1C >7.0% (uncontrolled)
  • Take blood glucose measurements as prescribed by their physician, or consistently (defined as missing no more than 1 reading from their regular routine).

You CAN'T join if...

  • Age < 50 years old
  • Not diagnosed with type 2 diabetes, or have diagnoses such as type 1 diabetes, gestational diabetes, or medication induced diabetes
  • Patients that are on medications that affect glycemic control
  • Corticosteroids
  • First-generation antipsychotics (e.g. chlorpromazine, perphenazine, phenothiazines)
  • Immunosuppressants (e.g. tacrolimus, cyclosporine)
  • Experiencing acute disease states
  • Recent surgery/hospitalized within the last 3 months
  • Active infections
  • Non-adherence to blood glucose monitoring (defined as missing > 1 reading from their regular routine or not taking readings as prescribed by their doctor)
  • Patients with late stage T2DM requiring insulin therapy
  • Diagnosed with cancer, end-stage renal disease, end-stage liver disease
  • Received any organ transplant

Lead Scientist at UCSF

  • Crystal Zhou, PharmD
    Associate Professor, Clinical Pharmacy, School of Pharmacy. Authored (or co-authored) 8 research publications. Research interests: Cardiology · Cardiovascular prevention · Primary prevention · Secondary prevention · Hypertension · Dyslipidemia · Heart Failure

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06861491
Study Type
Interventional
Participants
Expecting 200 study participants
Last Updated